Onkimmune Limited
Records under this name other than the patents Onkimmune Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 3 of 3 · Back to Onkimmune Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,906,951 | Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased Cytotoxicity Formerly held In force · High confidence | In force | High confidence | |
| US 10,799,536 | Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,034,925 | Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased Cytotoxicity Formerly held Lapsed on the fee record Ended Jul 31, 2026 · High confidence | Lapsed on the fee record | Ended Jul 31, 2026 | High confidence |